I definitely understand your frustration with the lack of PR and any frustrations with the management, but I am looking at the success of this chart from mainly a charting perspective. Without real news and publication of a license, this thing has basically moved 100%. What is going on is consolidation and getting that profit. I too am long and strong, I would say that considering the OTC the fact we have revenue and an actual living breathing CEO and a product you can actually seewe are in good hands. I actually find it refreshing there isn't a lot of fluff, when news comes it'll be substantial. Last but not least, we have a license for distribution. Stay patient, I think very soon things will be going yours and everyone's way.